Skip to content

Establishment of a dynamic symptom monitoring system for patients with adenomyosis after conservative treatment based on patient reported outcome

Establishment of a dynamic symptom monitoring system for patients with adenomyosis after conservative treatment based on patient reported outcome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000038590
Enrollment
Unknown
Registered
2020-09-24
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adenomyosis

Interventions

Qualitative interviews:no
Reliability and validity verification:no
Longitudinal cohort:no

Sponsors

Nanchong central hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) Aged over 18 years; (2) Premenopausal women with adenomyosis proposed; (3) Conservative treatment: focal resection (surgical approach: laparoscopic, transabdominal, etc.), uterine artery Embolism, high-intensity focused ultrasound (HIFU), radiofrequency ablation, Mirena ring, drug therapy, etc.; (4) Chief complaint: periodic pain related to the menstrual cycle (dysmenorrhea); pain during or after intercourse; lower abdomen or pelvis The periodic nature of pain; painful defecation, and any other pain symptoms related to endometriosis; (5) Able and willing to fill out electronic questionnaires on smartphones or tablets.

Exclusion criteria

Exclusion criteria: (1) Women with no symptoms of dysmenorrhea or infertility as the only chief complaint; (2) Pregnant or lactating women; (3) Unexplained or non-adenomyosis causes pelvic pain, vaginal bleeding and other symptoms; (4) Patients with severe heart, liver, and kidney diseases and adrenal insufficiency; (5) Women with abnormal gynecological examination results or abnormal cervical smear results in the past 3 months; (6) B-ultrasound diagnosis Benign lesions or suspected malignant tumors such as endometrial polyps and submucosal fibroids; (7) Women with coagulation abnormalities, other endocrine diseases, malignant or suspected malignant tumors; (8) Those who cannot understand the contents of the study.

Design outcomes

Primary

MeasureTime frame
recurrence rate;

Secondary

MeasureTime frame
Core symptom;pregnancy rate;

Countries

China

Contacts

Public ContactXU Fan

Nanchong Central Hospital, Sichuan Province

xufanyidingxin@163.com+86 15984877283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026